Dr. Paul Labinson, DO (he/him) is an Endocrinologist in Nashua, NH with over 17 years of experience. What is your opinion of Dr. Paul Labinson, DO? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Paul Labinson, DO has received over $18,759 which includes payments from the following companies:
$5,179.97 from Tandem Diabetes Care, Inc.
$2,493.14 from Novo Nordisk Inc
$1,395.57 from sanofi-aventis U.S. LLC
$1,226.68 from LILLY USA, LLC
$1,040.54 from AstraZeneca Pharmaceuticals LP
$712.68 from Amgen Inc.
$674.39 from Janssen Pharmaceuticals, Inc
$636.86 from Dexcom, Inc.
$514.86 from Boehringer Ingelheim Pharmaceuticals, Inc.
$505.18 from AbbVie, Inc.
$413.29 from Medtronic MiniMed, Inc.
$383.26 from Merck Sharp & Dohme Corporation
$326.86 from Abbott Laboratories
$274.08 from Corcept Therapeutics
$273.17 from Amarin Pharma Inc.
$223.32 from INSULET CORPORATION
$214.81 from Valeritas, Inc.
$174.93 from Takeda Pharmaceuticals America, Inc.
$161.59 from Ascensia Diabetes Care US Inc.
$153.22 from GlaxoSmithKline, LLC.
Payments received by Dr. Paul Labinson, DO were from the following categories:
$13,816.45 Food and Beverage
$4,654.14 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!